Kunkel Lori Anne
Kunkel Lori Anne, DIR, reported a transaction classified as exercise at Enliven Therapeutics, Inc. involving 7300.000000 shares for an estimated $0.00. Reported holdings after the transaction were 30582.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 30, 2026
- Filing date
- Nov 03, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ELVN price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001536368-26-000008 Stock Option (right to buy)
- Transaction date
- Oct 30, 2026 Filed Nov 03, 2026, 10:21 PM · 4d delay
- Shares
- 7,300 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 30,582 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
All of the shares subject to this option are fully vested and exercisable as of the date hereof.
- F2
The option, originally for 37,882 shares, of which 7,300 shares have been exercised, vests as to 1/36th of the shares on May 8, 2024 and each month thereafter, subject to the Reporting Person continui…
0 other transactions
0 recent txs